BioDelivery Sciences Announces Positive Meeting with FDA on a Streamlined ONSOLIS REMS with Broadened Distribution.
Business Wire › September 02, 2010
Linked as:
Extract
BioDelivery Sciences Announces Positive Meeting with FDA on a Streamlined ONSOLIS REMS with Broadened Distribution.
Recently Submitted REMS Amendment Seeks to Better Facilitate Physician Prescribing for Appropriate Patients and Improve Patient Access
RALEIGH, N.C. -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) today announced a positive meeting wi...See the full content of this document
Sponsored links
